Clinical trajectories of patients with multiple sclerosis from onset and their relationship with serum neurofilament light chain levels

被引:0
作者
Quintanilla-Bordas, Carlos [1 ]
Cubas-Nunez, Laura [1 ]
Castillo-Villalba, Jessica [1 ]
Carratala-Bosca, Sara [1 ]
Gasque-Rubio, Raquel [1 ]
Tortosa-Carreres, Jordi [2 ]
Alcala, Carmen [1 ]
Fores-Toribio, Lorena [1 ]
Lucas, Celia [3 ]
Gorriz, David [1 ]
Perez-Miralles, Francisco [1 ]
Casanova, Bonaventura [1 ]
机构
[1] Hlth Res Inst La Fe, Neuroimmunol Res Grp, Valencia, Spain
[2] Univ & Polytech Hosp La Fe, Lab Dept, Valencia, Spain
[3] Univ & Polytech Hosp La Fe, Syst & Applicat Engineer Dept, Valencia, Spain
来源
FRONTIERS IN NEUROLOGY | 2024年 / 15卷
关键词
multiple sclerosis; neurofilament light chain; progression; relapses; biomarkers; PROGRESSION;
D O I
10.3389/fneur.2024.1477335
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Serum neurofilament light chain (sNfL) is a biomarker of neuroaxonal destruction that correlates with acute inflammation (AI) in multiple sclerosis (MS). However, in the treatment era, progression without AI is the main driver of long-term disability. sNfL may provide added value in detecting ongoing axonal damage and neurological worsening in patients without AI. We conducted a prospective three-year study on patients with a first MS relapse to evaluate the basal cut-off value predicting early increased disability unrelated to relapses.Methods sNfL levels and AI presence were measured every 6 months during the first year and the Expanded Disability Status Scale (EDSS) was monitored until the third year. Baseline cohorts were stratified by sNfL levels, using a cut-off derived from patients without AI (absence of clinical relapses, new/enlarging T2 lesions, or gadolinium enhancement in magnetic resonance imaging) at year one.Results Fifty-one patients were included. A sNfL cut-off of 11 pg/mL predicted sustained neurological worsening independent of AI. Patients exceeding this threshold exhibited features of highly active MS (higher proportion of AI, oligoclonal M bands and higher EDSS). Despite AI ablation, sNfL levels persisted elevated and were significantly associated with increased EDSS at baseline and year 3. Patients with low sNfL and concurrent AI (n = 8) experienced relapses in the optic nerve, brainstem, and spinal cord topographies.Conclusion sNfL elevation may detect patients with increased disability even when AI is controlled. This may reveal mechanisms associated with early axonal degeneration and help identify patients at higher risk of progression.
引用
收藏
页数:8
相关论文
共 31 条
[1]   NFL during acute spinal cord lesions in MS: a hurdle for the detection of inflammatory activity [J].
Alcala, C. ;
Cubas, L. ;
Carratala, S. ;
Gascon, F. ;
Quintanilla-Bordas, C. ;
Gil-Perotin, S. ;
Gorriz, D. ;
Perez-Miralles, F. ;
Gasque, R. ;
Castillo, J. ;
Casanova, B. .
JOURNAL OF NEUROLOGY, 2022, 269 (07) :3495-3500
[2]   Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing-remitting multiple sclerosis: a 20-year follow-up cohort [J].
Arroyo Pereiro, Pablo ;
Munoz-Vendrell, Albert ;
Leon Moreno, Isabel ;
Bau, Laura ;
Matas, Elisabet ;
Romero-Pinel, Lucia ;
Yelamos, Antonio Martinez ;
Yelamos, Sergio Martinez ;
Andres-Benito, Pol .
JOURNAL OF NEUROLOGY, 2024, 271 (03) :1495-1496
[3]   Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis [J].
Barro, Christian ;
Benkert, Pascal ;
Disanto, Giulio ;
Tsagkas, Charidimos ;
Amann, Michael ;
Naegelin, Yvonne ;
Leppert, David ;
Gobbi, Claudio ;
Granziera, Cristina ;
Yaldizli, Ozgur ;
Michalak, Zuzanna ;
Wuerfel, Jens ;
Kappos, Ludwig ;
Parmar, Katrin ;
Kuhle, Jens .
BRAIN, 2018, 141 :2382-2391
[4]   Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study [J].
Benkert, Pascal ;
Meier, Stephanie ;
Schaedelin, Sabine ;
Manouchehrinia, Ali ;
Yaldizli, Ozgur ;
Maceski, Aleksandra ;
Oechtering, Johanna ;
Achtnichts, Lutz ;
Conen, David ;
Derfuss, Tobias ;
Lalive, Patrice H. ;
Mueller, Christian ;
Muller, Stefanie ;
Naegelin, Yvonne ;
Oksenberg, Jorge R. ;
Pot, Caroline ;
Salmen, Anke ;
Willemse, Eline ;
Kockum, Ingrid ;
Blennow, Kaj ;
Zetterberg, Henrik ;
Gobbi, Claudio ;
Kappos, Ludwig ;
Wiendl, Heinz ;
Berger, Klaus ;
Sormani, Maria Pia ;
Granziera, Cristina ;
Piehl, Fredrik ;
Leppert, David ;
Kuhle, Jens .
LANCET NEUROLOGY, 2022, 21 (03) :246-257
[5]   Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis [J].
Brune, Synne ;
Hogestol, Einar A. ;
de Rodez Benavent, Sigrid A. ;
Berg-Hansen, Pal ;
Beyer, Mona K. ;
Leikfoss, Ingvild Sorum ;
Bos, Steffan D. ;
Sowa, Piotr ;
Brunborg, Cathrine ;
Andorra, Magi ;
Pulido Valdeolivas, Irene ;
Asseyer, Susanna ;
Brandt, Alexander ;
Chien, Claudia ;
Scheel, Michael ;
Blennow, Kaj ;
Zetterberg, Henrik ;
Kerlero de Rosbo, Nicole ;
Paul, Friedemann ;
Uccelli, Antonio ;
Villoslada, Pablo ;
Berge, Tone ;
Harbo, Hanne F. .
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (12) :1859-1870
[6]   Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice [J].
Bruschi, Nicolo ;
Boffa, Giacomo ;
Inglese, Matilde .
EUROPEAN RADIOLOGY EXPERIMENTAL, 2020, 4 (01)
[7]   Oligoclonal M bands unveil occult inflammation in multiple sclerosis [J].
Casanova, Bonaventura ;
Castillo, Jessica ;
Quintanilla-Bordas, Carlos ;
Sanz, Maria T. ;
Fernandez-Velasco, Jose, I ;
Alcala, Carmen ;
Carratala, Sara ;
Gasque, Raquel ;
Rubio, Almudena ;
Cubas, Laura ;
Maria Villar, Luisa ;
Perez-Miralles, Francisco .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
[8]   Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis [J].
Chitnis, Tanuja ;
Gonzalez, Cindy ;
Healy, Brian C. ;
Saxena, Shrishti ;
Rosso, Mattia ;
Barro, Christian ;
Michalak, Zuzanna ;
Paul, Anu ;
Kivisakk, Pia ;
Diaz-Cruz, Camilo ;
Sattarnezhad, Neda ;
Pierre, Isabelle V. ;
Glanz, Bonnie I. ;
Tomic, Davorka ;
Kropshofer, Harald ;
Haring, Dieter ;
Leppert, David ;
Kappos, Ludwig ;
Bakshi, Rohit ;
Weiner, Howard L. ;
Kuhle, Jens .
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2018, 5 (12) :1478-1491
[9]   Serum neurofilament light chain levels predict long-term disability progression in patients with progressive multiple sclerosis [J].
Comabella, Manuel ;
Sastre-Garriga, Jaume ;
Carbonell-Mirabent, Pere ;
Fissolo, Nicolas ;
Tur, Carmen ;
Malhotra, Sunny ;
Pareto, Deborah ;
Aymerich, Francesc X. ;
Rio, Jordi ;
Rovira, Alex ;
Tintore, Mar ;
Montalban, Xavier .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (07) :732-740
[10]   Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis [J].
Disanto, Giulio ;
Barro, Christian ;
Benkert, Pascal ;
Naegelin, Yvonne ;
Schadelin, Sabine ;
Giardiello, Antonella ;
Zecca, Chiara ;
Blennow, Kaj ;
Zetterberg, Henrik ;
Leppert, David ;
Kappos, Ludwig ;
Gobbi, Claudio ;
Kuhle, Jens .
ANNALS OF NEUROLOGY, 2017, 81 (06) :857-870